The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy (SURE-Trial). Protocol for a Pilot, Open-Label Clinical Trial
Saved in:
| Main Authors: | Yuliya Knyahnytska, Reza Zomorrodi, Tyler Kaster, Daphne Voineskos, Trevizol Alisson, Daniel Blumberger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Brain Stimulation |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X24010520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model-based perturbational neurophysiological markers of TMS iTBS in Treatment-Resistant Depression
by: Davide Momi, et al.
Published: (2025-01-01) -
Tolerability and Clinical Outcomes with Anesthesia Dose Reduction during Electroconvulsive Therapy
by: Caroline Wanderley Espinola, et al.
Published: (2025-01-01) -
Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials
by: Xiao-Mei Li, et al.
Published: (2020-06-01) -
Comparison of combined intranasal dexmedetomidine and ketamine versus chloral hydrate for pediatric procedural sedation: a randomized controlled trial
by: Young-Eun Jang, et al.
Published: (2025-06-01) -
Efficacy and Safety of Cisatracurium in Electroconvulsive Therapy: A Randomized, Single-blind, Clinical Trial
by: Siamak Rimaz, et al.
Published: (2024-10-01)